PTC THERAPEUTICS, INC. — Director's Dealing 2017

Jan 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2017-01-05

Reporting Person: Almstead Neil Gregory (EVP Research Pharma Ops & Tech)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-05	Common Stock	S	78	$11.82	Disposed	2687	Indirect

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 187 RSUs from a January 4, 2016 grant of 750 shares.